Human embryos are at the center of a debate over the ethics of gene editing (credit: Dr. Yorgos Nikas/SPL)
The first application to pursue CRISPR/Cas9 genome-editing research in viable human embryos has been submitted to the UK’s fertility regulator by a team of researchers affiliated with the Francis Crick Institute in London.
Comments are closed.